People with PHTS can develop problems with blood or lymph vessels (which can be thought of as a waste collection system) called vascular anomalies (VAs). Research suggests that approximately 30–50% of people with PHTS are affected, although the true number is unknown and the severity can vary significantly from person to person. In people with PHTS, VAs are usually first seen in infancy or childhood. In some cases, VAs can cause serious health issues, and when very severe, can be life-threatening.
Researchers are working to better understand why VAs develop in first place and how they change over time. PTEN Research is currently supporting three projects that study these questions. The projects will utilise data and samples collected from people with PHTS VAs and use laboratory models of PHTS VAs.
The goal of this work is to improve how these conditions are diagnosed and treated. Ultimately, this research aims to turn scientific discoveries into better care and a higher quality of life for people living with PHTS and VAs.
Project title: Comprehensive Radiologic and Pathologic Phenotyping of Vascular Anomalies in PHTS: a retrospective clinical classification system based on expert consensus
Type of study: Clinical – classification of VAs in PHTS
Lead researcher: Prof Denise Adams
Institution: Children’s Hospital of Philadelphia
Project start: January 2022 Expected completion: December 2026
This study aims to create a classification system (a way to name and group VAs) for PHTS VAs.
There is a limited amount of information available about VAs in PHTS. This is a problem as it makes it more difficult to identify the right participants for potential future clinical trials. It also means that it’s difficult to know exactly which aspects of a person’s VA may improve with treatment and therefore makes it challenging to decide what improvement to look for in clinical trials. Experts also think that the VAs in PHTS are more complex in their presentation compared to other types of VAs caused other genetic changes.
In this retrospective study (looking back at past records), the researchers will examine medical records, scans and tissue reports from people with PHTS and VAs across multiple countries to describe exactly how their VAs look on medical imaging and under the microscope.
A more refined and PHTS-specific classification system for VAs in PHTS would make it easier for doctors and researchers to compare cases, design clinical trials, and predict outcomes to support better care and clearer information for families.
Project title: Lesion Onset and progression of vascular anomalies in PHTS
Type of study: Preclinical – PHTS model development and translational science
Lead researchers: Prof Mariona Graupera and Dr Sandra Castillo
Institution: Josep Carreras Leukemia Research Institute and Sant Joan de Déu Research Institute
Project start: June 2025 Expected completion: May 2029
The types of VAs seen in people with PHTS can vary from one person to another. Not all PHTS VAs start in the same way or develop in the same pattern over time. Some affect specific types of blood vessels like capillaries, veins, or lymph vessels, while others involve a combination, such as both arteries and veins.
This study aims to understand why VAs vary so much between people with PHTS and how these VAs start and develop over time.
The research group has previously discovered genetic changes associated with VAs in a type of cells in the blood vessel walls called endothelial cells.
In this project, the researchers will use laboratory models and tissue samples from people with PHTS to look at other types of cells to identify which types of cells in the blood vessels are responsible for different VAs. They will also explore whether external factors (for example, environment or other health issues) may affect how VAs grow and whether having both tumours and VAs affects outcomes.
The project will build a database of tissue and clinical information from people with PHTS and VAs, which will be used in laboratory testing and assessed using secure computational tools. This is hoped to speed up development of new or repurposed treatments and improve diagnosis.
Project title: Exploring a Two-Hit Genetic Model in PTEN Hamartoma Syndrome related Vascular Anomalies
Type of study: Preclinical – PHTS model and translational
Lead researcher: Prof Michael Hildebrand
Institution: University of Melbourne
Project start: August 2025 Expected completion: September 2028
This project will investigate if VAs develop when a variant of the PTEN gene, which is present in every single cell of a person with PHTS following fertilisation of the embryo, is combined with an additional genetic change which may occur later in life - a so called ‘second hit’.
In this study, genetic testing of tissue samples from approximately 42 people with VAs or other lesions and confirmed or suspected PHTS in Australia will be undertaken
The study will use sensitive testing methods to discover changes in DNA within 138 genes linked to VAs or cancers.
This is the first time researchers are looking at these second genetic changes in PHTS-associated VAs on a large scale. Having more information on the genetic changes in VAs will hopefully help us understand why VAs look and behave so differently between people with PHTS. It could also improve genetic diagnosis, help identify people who might benefit from specific clinical trials, and support better treatment choices for individuals in the future. The project will also look for second genetic changes in tissue samples available from other lesions (e.g., hamartomas).